Hamman-Rich syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
Chandrakala Yannam (talk | contribs)
No edit summary
Chandrakala Yannam (talk | contribs)
No edit summary
Line 35: Line 35:


===Pathogenesis===
===Pathogenesis===
*The exact pathogenesis of [disease name] is not fully understood.
*The exact pathogenesis acute interstitial pneumonitis is not fully understood.
OR
*The mechanism of initial injury to the pulmonary epithelium is not known.
*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
*Diffuse alveolar damage occurs in 3 stages.<ref name="pmid23028252">{{cite journal |vauthors=Nur Urer H, Ersoy G, Yılmazbayhan ED |title=Diffuse alveolar damage of the lungs in forensic autopsies: assessment of histopathological stages and causes of death |journal=ScientificWorldJournal |volume=2012 |issue= |pages=657316 |date=2012 |pmid=23028252 |pmc=3458269 |doi=10.1100/2012/657316 |url=}}</ref><ref name="pmid19647854">{{cite journal |vauthors=Kang D, Nakayama T, Togashi M, Yamamoto M, Takahashi M, Kunugi S, Ishizaki M, Fukuda Y |title=Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome |journal=Hum. Pathol. |volume=40 |issue=11 |pages=1618–27 |date=November 2009 |pmid=19647854 |doi=10.1016/j.humpath.2009.04.019 |url=}}</ref>
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
**Acute exudative
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
**Proliferative organizing
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
**Fibrotic
*The progression to [disease name] usually involves the [molecular pathway].
*The rapid and abrupt onset of a widespread injury pattern may be suggested as an initiating factor involving pulmonary endothelium. This is followed by damage to alveolar epithelium and cell death, that leads to release of mediating factors such as tumor necrosis factor alpha, interleukins and monocyte chemoattractant factor.
*The pathophysiology of [disease/malignancy] depends on the histological subtype.
*Followed by the influx of neutrophils into the alveolar spaces and alveolar walls leads to further cellular damage, by the release of toxic oxygen free radicals and proteases.  
 
*Neutrophils and other inflammatory cells can contribute to the progression of the epithelial cell injury and airspace exudation.  
==Genetics==
*The extent of epithelial injury and basement membrane damage may modulate the nature and extent of the subsequent fibroblastic response in AIP.
*[Disease name] is transmitted in [mode of genetic transmission] pattern.
*Following the acute phase, a stage of organization occurs.  
*Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
**The hyaline membranes are resorbed into the alveolar septa and overgrown by proliferating type II pneumocytes.
*The development of [disease name] is the result of multiple genetic mutations.
*In fibrotic phase, proliferation of fibroblasts and differentiation into myofibroblasts leads to production of collagen, causes widening of the alveolar septae, and organization of the alveolar exudate
 
*Collapse of alveolar wall and apposition, associated with reepithelization of the fibrotic exudate within the alveolar space may contribute to the severity and extent of the fibrotic process.
==Associated Conditions==
*Resolution of the injury occurs in some patients, others develop a progressive fibrotic response.


==Gross Pathology==
==Gross Pathology==

Revision as of 20:23, 20 March 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathophysiology

Pathogenesis

  • The exact pathogenesis acute interstitial pneumonitis is not fully understood.
  • The mechanism of initial injury to the pulmonary epithelium is not known.
  • Diffuse alveolar damage occurs in 3 stages.[1][2]
    • Acute exudative
    • Proliferative organizing
    • Fibrotic
  • The rapid and abrupt onset of a widespread injury pattern may be suggested as an initiating factor involving pulmonary endothelium. This is followed by damage to alveolar epithelium and cell death, that leads to release of mediating factors such as tumor necrosis factor alpha, interleukins and monocyte chemoattractant factor.
  • Followed by the influx of neutrophils into the alveolar spaces and alveolar walls leads to further cellular damage, by the release of toxic oxygen free radicals and proteases.
  • Neutrophils and other inflammatory cells can contribute to the progression of the epithelial cell injury and airspace exudation.
  • The extent of epithelial injury and basement membrane damage may modulate the nature and extent of the subsequent fibroblastic response in AIP.
  • Following the acute phase, a stage of organization occurs.
    • The hyaline membranes are resorbed into the alveolar septa and overgrown by proliferating type II pneumocytes.
  • In fibrotic phase, proliferation of fibroblasts and differentiation into myofibroblasts leads to production of collagen, causes widening of the alveolar septae, and organization of the alveolar exudate
  • Collapse of alveolar wall and apposition, associated with reepithelization of the fibrotic exudate within the alveolar space may contribute to the severity and extent of the fibrotic process.
  • Resolution of the injury occurs in some patients, others develop a progressive fibrotic response.

Gross Pathology

Microscopic Pathology

References

  1. Nur Urer H, Ersoy G, Yılmazbayhan ED (2012). "Diffuse alveolar damage of the lungs in forensic autopsies: assessment of histopathological stages and causes of death". ScientificWorldJournal. 2012: 657316. doi:10.1100/2012/657316. PMC 3458269. PMID 23028252.
  2. Kang D, Nakayama T, Togashi M, Yamamoto M, Takahashi M, Kunugi S, Ishizaki M, Fukuda Y (November 2009). "Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome". Hum. Pathol. 40 (11): 1618–27. doi:10.1016/j.humpath.2009.04.019. PMID 19647854.
  3. Tomashefski JF (September 2000). "Pulmonary pathology of acute respiratory distress syndrome". Clin. Chest Med. 21 (3): 435–66. PMID 11019719.
  4. Mukhopadhyay S, Parambil JG (October 2012). "Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS)". Semin Respir Crit Care Med. 33 (5): 476–85. doi:10.1055/s-0032-1325158. PMID 23001802.
  5. Bonaccorsi A, Cancellieri A, Chilosi M, Trisolini R, Boaron M, Crimi N, Poletti V (January 2003). "Acute interstitial pneumonia: report of a series". Eur. Respir. J. 21 (1): 187–91. PMID 12570127.

Template:WH Template:WS

References

Template:WH Template:WS